(Q35114512)

6 August 2017

title

HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy (English)

1 reference

6 August 2017

main subject

anti-retroviral agent

0 references

1 reference

Isabelle Poizot-Martin

7

Isabelle Poizot-Martin

1 reference

6 August 2017

Dominique Costagliola

10

Dominique Costagliola

0 references

Emilie Lanoy

1

Emilie Lanoy

0 references

James J Goedert

11

James J Goedert

1 reference

6 August 2017

Philip S Rosenberg

2

1 reference

6 August 2017

Fabien Fily

3

1 reference

6 August 2017

Anne-Sophie Lascaux

4

1 reference

6 August 2017

Valerie Martinez

5

1 reference

6 August 2017

Maria Partisani

6

1 reference

6 August 2017

Elisabeth Rouveix

8

1 reference

6 August 2017

Eric A Engels

9

1 reference

6 August 2017

FHDH-ANRS CO4

12

1 reference

6 August 2017

language of work or name

English

0 references

publication date

6 May 2011

1 reference

6 August 2017

1 reference

6 August 2017

volume

118

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

44-49

1 reference

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/TARC.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

HIV-associated Hodgkin lymphoma.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Hodgkin lymphoma in the Swiss HIV Cohort Study

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Trends in cancer risk among people with AIDS in the United States 1980-2002.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Immune restoration disease after antiretroviral therapy

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Spectrum of AIDS-associated malignant disorders

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term follow-up

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Cancer risk in people infected with human immunodeficiency virus in the United States

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Classical Hodgkin's lymphoma: molecular evidence for specific alterations in circulating T lymphocytes.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22

8 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139385

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003

8 December 2018

1 reference

12 December 2020

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

1 reference

12 December 2020

TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma

1 reference

12 December 2020

Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy

1 reference

12 December 2020

Immune deficiency and risk for malignancy among persons with AIDS

1 reference

12 December 2020

Displacement of T lymphocytes with the 'Helper/Inducer' phenotype from peripheral blood to lymphoid organs in untreated patients with Hodgkin's disease

1 reference

12 December 2020

Expanded European AIDS case definition

1 reference

12 December 2020

Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors

1 reference

12 December 2020

Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV

1 reference

12 December 2020

Immunoregulatory T cells in the peripheral blood of patients with Hodgkin's lymphoma

1 reference

12 December 2020

10.1182/BLOOD-2011-02-339275

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference